Pertuzumab (anti-HER2)
Pertuzumab (anti-HER2), a humanized monoclonal antibody, is a HER2 dimerization inhibitor for the treatment of metastatic HER2-positive breast cancer.
Product Specifications
CAS Number
[380610-27-5]
UNSPSC
12352203
Target
EGFR
Type
Inhibitory Antibodies
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pertuzumab-anti-her2.html
Purity
99.10
Solubility
H2O
Smiles
[Pertuzumab(anti-HER2)]
Molecular Weight
(144 kDa)
References & Citations
[1]Nahta R, et al. The HER-2-targeting antibodies trastuzumab and pertuzumab synergistically inhibit the survivalof breast cancer cells. Cancer Res. 2004 Apr 1;64 (7) :2343-6.|[2]Scheuer W, et al. Strongly enhanced antitumor activity of trastuzumab and pertuzumab combination treatment on HER2-positive human xenograft tumor models. Cancer Res. 2009 Dec 15;69 (24) :9330-6.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
ErbB2/HER2
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
![CHCHD3 Mouse Monoclonal Antibody [Clone ID: LBI3E10]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
AMM16049V 100 µL
CHCHD3 Mouse Monoclonal Antibody [Clone ID: LBI3E10]
Sign In for Pricing
View Details 
MBS6359778-01 0.1 mL
Tssk6, CT (Tssk6, Sstk, Testis-specific serine/threonine-protein kinase 6, Serine/threonine-protein kinase SSTK, Small serine/threonine kinase) (MaxLight 550)
Sign In for Pricing
View Details MBS6359778-02 5x 0.1 mL
Tssk6, CT (Tssk6, Sstk, Testis-specific serine/threonine-protein kinase 6, Serine/threonine-protein kinase SSTK, Small serine/threonine kinase) (MaxLight 550)
Sign In for Pricing
View Details 
585330-01 20 µg
Mast Cell Protease 4, Recombinant, Rat, aa21-246, His-Tag, Myc-Tag
Sign In for Pricing
View Details